Bit Bio’s “enter button for the keyboard to the software of life” nabs the company $41.5 million – TechCrunch

Arch Venture Partners, biology, biotechnology, BlueYard Capital, cambridge university, cancer, CRISPR, Director, Disease, drug development, drug discovery, Foresite Capital, founder, Grail, Juno, Life Sciences, Meatable, operating system, stem cells, TC, United Kingdom

[ad_1] Bit Bio, the new startup which pitches itself as the “enter button for the keyboard to the software of life” only needed three weeks to raise its latest $41.5 million round of funding. Originally known as Elpis Biotechnology and named for the Greek goddess of hope, the Cambridge, England-based company was founded by Mark…

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic – TechCrunch

biology, biotechnology, cancer, Disease, Life Sciences, new enterprise associates, TC, tumor

[ad_1] Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration for its PGDx elio tissue complete test. The test’s approval is another step forward for precision therapies that rely on an understanding of the…